z-logo
open-access-imgOpen Access
Cytotoxicity of anticancer aziridinyl-substituted benzoquinones in primary mice splenocytes.
Author(s) -
Valė Miliukienė,
Henrikas Nivinskas,
Narimantas Čėnas
Publication year - 2014
Publication title -
acta biochimica polonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.452
H-Index - 78
eISSN - 1734-154X
pISSN - 0001-527X
DOI - 10.18388/abp.2014_1854
Subject(s) - cytotoxicity , splenocyte , chemistry , cytotoxic t cell , oxidative stress , stereochemistry , biochemistry , in vitro
UNLABELLEDThe anticancer activity of aziridinyl-quinones is mainly attributed to theirNAD(P)Hquinone oxidoreductase 1 (NQO1)-catalyzed two-electron reduction into DNA-alkylating products. However, little is known about their cytotoxicity in primary cells, which may be important in understanding their side effects. We found that the cytotoxicity of aziridinyl-unsubstituted quinones (n = 12) in mice splenocytes with a low amount of NQO1, 4 nmol × mg(-1) × min(-1), was caused mainly by the oxidative stress. Aziridinyl-benzoquinones (n = 6) including a novel anticancer agent RH1 were more cytotoxic than aziridinyl-unsubstituted ones with the similar redox properties, and their cytotoxicity was not decreased by an inhibitor of NQO1, dicumarol. The possible reasons for their enhanced cytotoxicity are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom